Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Pain and Headache Reports
Erschienen in: Current Pain and Headache Reports 4/2022

01.04.2022 | Episodic Migraine (S Nahas, Section Editor)

Integrative, Interventional, and Non-invasive Approaches for the Treatment for Migraine During Pregnancy

verfasst von: Ashley Holdridge, Megan Donnelly, Deena E. Kuruvilla

Erschienen in: Current Pain and Headache Reports | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

While most women with migraine improve during pregnancy, a subset may remain unchanged or even become more severe. Given the limited evidence for the use of prescription medications during pregnancy, many look to other treatment modalities. We seek to review complementary and integrative medicine, procedural interventions, and neurostimulation to empower women with safe and effective treatment options during pregnancy.

Recent Findings

Migraine treatment during pregnancy remains controversial. While evidence is limited, prospective and retrospective reviews, as well as clinical experience support the use of nutraceuticals, procedural interventions, and neurostimulation during pregnancy when the appropriate risks and benefits are weighed.

Summary

Empowering patients with information on complementary and integrative medicine, as well as non-systemic and interventional treatments, may help to reduce anxiety and headache burden during pregnancy. Various nutraceuticals have shown promise for the preventive management of migraine. Non-systemic interventions such as trigger point injections and peripheral and sphenopalatine nerve blocks offer effective treatment options with minimal side-effects. Options for neurostimulation have expanded in recent years and may offer safe and effective non-pharmacologic options for the management of migraine. It is imperative that providers do not minimize migraine during pregnancy and become aware of the treatment modalities available to help guide women through this experience.
Literatur
1.
Saldanha IJ, Cao W, Bhuma MR, Konnyu KJ, Adam GP, Mehta S, Zullo AR, Chen KK, Roth JL, Balk EM. Management of primary headaches during pregnancy, postpartum, and breastfeeding: A systematic review. Headache. 2022;61(1):11–43.CrossRef
2.
3.
Ishii R, Schwedt TJ, Kim SK, Dumkrieger G, Chong CD, Dodick DW. Effect of migraine on pregnancy planning: insights from the American Registry for Migraine Research. In Mayo Clinic Proceedings 2020;95(10):2079–2089.CrossRef
4.
Kvisvik EV, Stovner LJ, Helde G, Bovim G, Linde M. Headache and migraine during pregnancy and puerperium: the MIGRA-study. J Headache Pain. 2011;12(4), 443–451.CrossRef
5.
Burch RC, Buse DC, Lipton RB. Migraine: epidemiology, burden, and comorbidity. Neurol Clin. 2019;37(4), 631–649.CrossRef
6.
7.
• Burch R. Epidemiology and treatment of menstrual migraine and migraine during pregnancy and lactation: a narrative review. Headache. 2020. This paper gives an updated review of the safety profile in pregnancy and lactation of Medications commonly used in migraine rescue and prevention. 
8.
9.
Pernia S, DeMaagd G. The New Pregnancy and Lactation Labeling Rule. P&T: A Peer-Reviewed Journal for Formulary Management 2006;41(11):713–715.
10.
11.
Kuruvilla DE, Mehta A, Ravishankar N, Cowan RP. A patient perspective of complementary and integrative medicine (CIM) for migraine treatment: a social media survey. BMC Complementary Medicine and Therapies. 2021;21(1):58.CrossRef
12.
Zhang Y, Dennis JA, Leach MJ, Bishop FL, Cramer H, Chung VC, Moore C, Lauche R, Cook R, Sibbritt D, Adams J. Complementary and alternative medicine use among US adults with headache or migraine: results from the 2012 National Health Interview Survey. Headache. 2017;57(8):1228–1242.CrossRef
13.
Thompson DF, Saluja HS. Prophylaxis of migraine headaches with riboflavin: a systematic review. J Clin Pharm Ther. 2017;42(4), 394–403.CrossRef
14.
• Kuruvilla D, Wells RE. Evidence Based Integrative Treatments for Headache. Headache. 2019;59(6) 971–972. This toolbox highlights evidence based integrative treatments for the treatment of headache disorders and reviews the possible adverse effects of these natural treatment approaches.
15.
Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16 (4):257–63.
16.
Makrides M, Crosby D, Bain E, and Crowther CA. Magnesium supplementation in pregnancy. Cochrane Database of Syst Rev. 2014;4(April):CD000937.
17.
de Araújo CA, Ray JG, Figueiroa JN, Alves JG. BRAzil magnesium (BRAMAG) trial: A double-masked randomized clinical trial of oral magnesium supplementation in pregnancy. BMC Pregnancy Childbirth. 2020;20(1):234.CrossRef
18.
19.
20.
Institute of Medicine, Food and Nutrition Board, and A Report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline and Subcommittee on Upper Reference Levels of Nutrients. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academies Press. 2000.
21.
22.
Teran E, Hernandez I, Nieto B, Tavara R, Ocampo JE, Calle A. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia. Int J Gynaecol Obstet. 2009;105(1):43–45.CrossRef
23.
• Ghorbani Z, Rafiee P, Fotouhi A, Haghighi S, Magham RR, Ahmadi ZS, Djalali M, Zareei M, Jahromi SR, Shahemi S, Mahmoudi M. The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial. J Headache Pain. 2020. 21(1):22. This article suggests the possible role of Vitmain D in improving migraine via decreasing levels of CGRP.
24.
Liampas I, Siokas V, Brotis A, Dardiotis E. Vitamin D serum levels in patients with migraine: A meta-analysis. Revue Neurologique. 2020;176(7–8):560–570.CrossRef
25.
Zhang YF, Xu ZQ, Zhou HJ, Liu YZ, Jiang XJ. The Efficacy of Vitamin D Supplementation for Migraine: A Meta-Analysis of Randomized Controlled Studies. Clin Neuropharmacol. 2021;44(1):5–8.CrossRef
26.
27.
Mithal A, Kalra S. Vitamin D supplementation in pregnancy. Indian J Endocrinol Metab. 2014;18(5), 593–596.CrossRef
28.
Gonçalves AL, Ferreira AM, Ribeiro RT, Zukerman E, Cipolla-Neto J, Peres MF. Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. J Neurol Neurosurg Psychiatry. 2016;87(10):1127–1132.CrossRef
29.
Guilbot A, Bangratz M, Ait Abdellah S, Lucas C. A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study. BMC Complement Altern Med. 2017;17(1):433.CrossRef
30.
Negro A, Delaruelle Z, Ivanova TA, Khan S, Ornello R, Raffaelli B, Terrin A, Reuter U, Mitsikostas DD, EHF School of Advanced Studies (EHF-SAS). J Headache Pain 2017;18(1):106.
31.
Lipchik GL, Smitherman TA, Penzien DB, Holroyd KA. Basic principles and techniques of cognitive‐behavioral therapies for comorbid psychiatric symptoms among headache patients. Headache. 2006;46(Suppl 3):S119–32.
32.
Wallasch TM, Angeli A, Kropp P. Outcomes of a headache-specific cross-sectional multidisciplinary treatment program. Headache 2012;52(7):1094–1105.CrossRef
33.
Holroyd KA. Behavioral and psychologic aspects of the pathophysiology and management of tension-type headache. Curr Pain Headache Rep 2002;6(5):401–407.CrossRef
34.
35.
Mehra A, Grover S. Biofeedback intervention during the pregnancy for the treatment of anxiety disorder: A case report and review of literature. Indian J Psychiatry. 2020;62(5):588–590.CrossRef
36.
Zhang N, Houle T, Hindiyeh N, Aurora SK. Systematic review: acupuncture vs standard pharmacological therapy for migraine prevention. Headache. 2020;60(2):309–317.CrossRef
37.
38.
39.
Tang YW, Cui X, Liu K, Li XX, Han S, Zhao J, Wang SY, Chen YY, Gao XY, Zhu B. Manual acupuncture stimulation of acupoints at the same and adjacent spinal segments promotes uterine contractility. Zhen ci yan jiu= Acupuncture Research. 2020;45(9):708–13.
40.
Mehta JN, Parikh S, Desai SD, Solanki RC, Pathak AG. Study of additive effect of yoga and physical therapies to standard pharmacologic treatment in migraine. Journal of Neurosciences in Rural Practice. 2021;12(1):60–66.CrossRef
41.
Babbar S, Shyken J. Yoga in pregnancy. Clin Obstet Gynaecol. 2016;59(3):600–612.CrossRef
42.
Ferreira CWS, Alburquerque-Sendi NF. Effectiveness of physical therapy for pregnancy-related low back and/or pelvic pain after delivery: a systematic review. Physiother Theory Pract. 2013;29(6):419–431.CrossRef
43.
Ashkenazi A, Matro R, Shaw JW, Abbas MA, Silberstein SD. Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study. J Neurol Neurosurg Psychiatry. 2008;79(4):415–417.CrossRef
44.
45.
Blumenfeld A, Ashkenazi A, Napchan U, Bender SD, Klein BC, Berliner R, Ailani J, et al. Expert consensus recommendations for the performance of peripheral nerve blocks for headaches–a narrative review. Headache 2013;53(3):437–446.CrossRef
46.
Blumenfeld A, Ashkenazi A, Grosberg B, Napchan U, Narouze S, Nett B, DePalma T, Rosenthal B, et al. Patterns of use of peripheral nerve blocks and trigger point injections among headache practitioners in the USA: results of the American Headache Society Interventional Procedure Survey (AHS-IPS). Headache. 2010. https://​doi.​org/​10.​1111/​j.​1526-4610.​2010.​01676.​x.
47.
Alvarez DJ, Rockwell PG. Trigger points: diagnosis and management. Am Fam Physician 2002;65(4):653–660.PubMed
48.
49.
Robbins MS, Kuruvilla D, Blumenfeld A, Charleston IV L, Sorrell M, Robertson CE, Grosberg BM, Bender SD, Napchan U, Ashkenazi A. Trigger point injections for headache disorders: expert consensus methodology and narrative review. Headache. 2014;54(9):1441-59.
50.
Tsen LC, Camann WR. Trigger point injections for myofascial pain during epidural analgesia for labor. Reg Anesth. 1997;22(5):466–468.CrossRef
51.
Binfalah M, Alghawi E, Shosha E, Alhilly A, Bakhiet M. Sphenopalatine ganglion block for the treatment of acute migraine headache. Pain Res Treat. 2018(May):2516953.PubMedPubMedCentral
52.
Yarnitsky D, Goor‐Aryeh I, Bajwa ZH, Ransil BI, Cutrer FM, Sottile A, Burstein R. 2003 Wolff Award: possible parasympathetic contributions to peripheral and central sensitization during migraine. Headache: The journal of head and face pain. 2003;43(7):704–714.CrossRef
53.
54.
Levin D, Cohen S, Mellender S, Kiss G. Sphenopalatine ganglion block successfully treats migraines in a type 1 Arnold Chiari malformation pregnant patient: a case report. A&A Practice. 2018;11(2), 32–34.CrossRef
55.
56.
Brin MF, Kirby RS, Slavotinek A, Miller‐Messana MA, Parker L, Yushmanova I, Yang H. Pregnancy outcomes following exposure to onabotulinumtoxinA. Pharmacoepidemiol Drig Saf. 2016.
57.
• Wong HT, Khalil M, Ahmed F. OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients. J Headache Pain. 2020;21(1):129. This study reviews the largest cohort of people with migraine documented who received botox during pregnancy to date.
58.
• Robinson AY, Grogan PM. OnabotulinumtoxinA successfully used as migraine prophylaxis during pregnancy: a case report. Mil Med. 2014;179(6):e703-4. Longest reported follow-up period for a child whose mother received BoNTA during pregnancy.
59.
Chou DE, Shnayderman Yugrakh M, Winegarner D, Rowe V, Kuruvilla D, Schoenen J. Acute migraine therapy with external trigeminal neurostimulation (ACME): a randomized controlled trial. Cephalalgia. 2019;39(1):3–14.
60.
Yarnitsky D, Dodick DW, Grosberg BM, Burstein R, Ironi A, Harris D, Lin T, Silberstein SD. Remote electrical neuromodulation (REN) relieves acute migraine: A randomized, double‐blind, placebo‐controlled, multicenter trial. Headache. 2019;59(8):1240–1252.CrossRef
61.
Mwamburi M, Liebler EJ, Tenaglia AT. Review of non-invasive vagus nerve stimulation (gammaCore): efficacy, safety, potential impact on comorbidities, and economic burden for episodic and chronic cluster headache. Am J Manag Care. 2017;23(17 Suppl):S317–S325.PubMed
62.
Andreou AP, Holland PR, Akerman S, Summ O, Fredrick J, Goadsby PJ. Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine. Brain. 2016;139(Pt 7):2002–14.
63.
Metadaten
Titel
Integrative, Interventional, and Non-invasive Approaches for the Treatment for Migraine During Pregnancy
verfasst von
Ashley Holdridge
Megan Donnelly
Deena E. Kuruvilla
Publikationsdatum
01.04.2022
Verlag
Springer US
Erschienen in
Current Pain and Headache Reports / Ausgabe 4/2022
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-022-01028-8

Weitere Artikel der Ausgabe 4/2022

Current Pain and Headache Reports 4/2022 Zur Ausgabe

Hot Topics in Pain and Headache (N Rosen, Section Editor)

Managing Headache Disorders Associated with Tuberous Sclerosis and Neurofibromatosis

Regenerative Pain Medicine/Interventional Pain Medicine (E Cornett Bradley, Section Editor)

Occipital Nerve Stimulation: An Alternative Treatment of Chronic Migraine

Acute Pain Medicine (R Urman, Section Editor)

Perioperative Breast Analgesia: a Systematic Review of the Evidence for Perioperative Analgesic Medications

Episodic Migraine (S Nahas, Section Editor)

Episodic Migraine and Older Adults

Chronic Daily Headache (SJ Wang and S Chen, Section Editors)

Resting State Electrophysiological Cortical Activity: A Brain Signature Candidate for Patients with Migraine

Neu im Fachgebiet AINS

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise